The PrisMax system is designed to maximize confidence in the delivery of CRRT and other organ support therapies. Building on 20+ years of critical care expertise, our system aims to support you in meeting the evolving needs of your ICU to optimize therapy delivery and the quality of patient care now and in the future through enhanced simplicity ...

The PrisMax system delivers multiple modes of Continuous Renal Replacement Therapy (CRRT) without the need for additional equipment.

Simplify the complexities of CRRT and other extracorporeal therapies with the user-friendly interface of the PrisMax 2 system that helps enable seamless therapy management, from set-up to delivery.

May 25, 2021 · PrisMax 2 is designed to help simplify delivery of continuous renal replacement therapy (CRRT) and other organ support therapies, while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU).

Building on 20-plus years of critical care expertise, the PRISMAX system helps clinicians meet the evolving needs of their ICU to maximize therapy delivery and the quality of patient care now and in the future through enhanced simplicity, efficiency and accuracy.

Enables precise control of blood return temperature between 35 °C and 38 °C, all managed through the PrisMax System interface.* Independent from fluid flow rates and therapy interruptions.

As an evolution of the PrisMax platform, Baxter now launches the PrisMax 2 system built on feedback from healthcare professionals from all over the world. The new system takes extracorporeal therapies to the next level while it further improves user experience and optimizes efficiencies with wireless EMR connectivity – all to maximize ...

Oct 29, 2018 · Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today the company received CE mark of both its PrisMax system and its TherMax blood warmer. PrisMax is the company’s next-generation technology for continuous renal replacement and organ support therapies.

Jul 29, 2019 · Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today 510 (k) clearance of the PrisMax system and the integrated TherMax blood warmer, the company’s next-generation platform for continuous renal replacement therapy.

The PRISMAX System is intended for: Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload. Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated. Rx Only.